GLP-1 inhibitors may curb heart failure risk in diabetes

03/26/2013 | MedPage Today (free registration)

Diabetes patients taking GLP-1 inhibitors were 41% less likely to develop heart failure compared with those on other glucose-lowering medications, a study indicated. Researchers also found the patients on GLP-1 inhibitors had a 44% lower risk of all-cause hospitalization and an 80% lower risk of all-cause mortality than those not on such medications. The findings were presented at the American College of Cardiology meeting.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN